CNW/ - Takeda Canada Inc. ("Takeda") is pleased to announce that Health Canada has provided market authorization for ...

Among the myriad drugmakers laying out their plans for the future at this year’s J.P. Morgan Healthcare Conference, Takeda ...

Takeda Canada said Health Canada has provided market authorization for FRUZAQLA, indicated for the treatment of adult patients with ...

Experience the craftsmanship behind the MOSHOW metal frame Takeda Shingen special version. This limited edition showcases intricate design and precision, capturing the essence of Takeda Shingen’s ...

Global biopharmaceutical giant Takeda opens its first Asian Innovation Capability Centre in Bengaluru to speed up drug ...

Takeda has opened an innovation capability centre (ICC) in Bengaluru to leverage the local tech talent pool for building core ...

The Innovation Capability Centre plans to hire 750 professionals, including software engineers, data scientists, and ...

The flagship ICC in Bengaluru complements Takeda's existing centres in Slovakia and Mexico, highlighting its strategic focus ...

Takeda's Bengaluru ICC focuses on innovative healthcare solutions, leveraging AI and data analytics for patient care ...

DelveInsight's“Bullous Pemphigoid Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Bullous Pemphigoid, historical and forecasted epidemiology as ...

As the J.P. Morgan Healthcare Conference started in San Francisco on Monday, AbbVie linked up with Simcere with a $1 billion ...